BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 34509035)

  • 1. Comparison of healthcare resource utilization in pediatric patients with refractory epilepsy: Vagus nerve stimulation and medical treatment cohorts.
    Zhang L; Wu JY; Lam SK
    Epilepsy Behav; 2021 Oct; 123():108281. PubMed ID: 34509035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospital costs associated with vagus nerve stimulation and medical treatment in pediatric patients with refractory epilepsy.
    Zhang L; Hall M; Lam SK
    Epilepsia; 2022 May; 63(5):1141-1151. PubMed ID: 35188675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes, quality of life, and costs associated with implantation of vagus nerve stimulation therapy in pediatric patients with drug-resistant epilepsy.
    Helmers SL; Duh MS; Guérin A; Sarda SP; Samuelson TM; Bunker MT; Olin BD; Jackson SD; Faught E
    Eur J Paediatr Neurol; 2012 Sep; 16(5):449-58. PubMed ID: 22261080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effectiveness of Medical and Surgical Treatment for Children With Refractory Epilepsy.
    Pan I; LoPresti MA; Clarke DF; Lam S
    Neurosurgery; 2020 Dec; 88(1):E73-E82. PubMed ID: 32710761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of vagus nerve stimulation on secondary care burden in children and adults with epilepsy: Review of routinely collected hospital data in England.
    Camp C; Smithson WH; Bunker M; Burke T; Hughes D
    Epilepsy Behav; 2015 Nov; 52(Pt A):68-73. PubMed ID: 26409132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of pharmacotherapy regimen and costs in patients with drug-resistant epilepsy following vagus nerve stimulation therapy: a single-center study (Poland).
    Kopciuch D; Barciszewska AM; Fliciński J; Zaprutko T; Kus K; Steinborn B; Nowakowska E
    Acta Neurol Belg; 2020 Feb; 120(1):115-122. PubMed ID: 31721076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of long-term survival with continued medical therapy, vagus nerve stimulation, and cranial epilepsy surgery in paediatric patients with drug-resistant epilepsy in the USA: an observational cohort study.
    Zhang L; Hall M; Lam SK
    Lancet Child Adolesc Health; 2023 Jul; 7(7):455-462. PubMed ID: 37276875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of utilization and cost of healthcare services and pharmacotherapy following implantation of vagus nerve stimulation
    Vincent T; Li Q; Zhang L; Stokes M; Danielson V; Murphy J; Barion F; Lam S; Lassagne R; Berger A
    J Med Econ; 2022; 25(1):1218-1230. PubMed ID: 36384429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Vagus Nerve Stimulation for the Treatment of Drug-resistant Epilepsy on Patterns of Use and Cost of Health Care Services and Pharmacotherapy: Comparisons of the 24-Month Periods Before and After Implantation.
    Evans K; Stamas N; Li Q; Vincent T; Halchenko Y; Zhang L; Danielson V; Murphy J; Barion F; Lam S; Lassagne R; Berger A
    Clin Ther; 2023 Feb; 45(2):136-150. PubMed ID: 36746736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vagus nerve stimulation for refractory epilepsy: experience from Saudi Arabia.
    Al-Said Y; Baeesa S; Khalid M; Abdeen M; Kayyali HR
    Ann Saudi Med; 2015; 35(1):41-5. PubMed ID: 26142937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug resistant epilepsy in the United States.
    Raspin C; Faught E; Armand J; Barion F; Pollit V; Murphy J; Danielson V
    J Med Econ; 2023; 26(1):189-199. PubMed ID: 36691763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vagus nerve stimulation for drug-resistant epilepsy: a European long-term study up to 24 months in 347 children.
    Orosz I; McCormick D; Zamponi N; Varadkar S; Feucht M; Parain D; Griens R; Vallée L; Boon P; Rittey C; Jayewardene AK; Bunker M; Arzimanoglou A; Lagae L
    Epilepsia; 2014 Oct; 55(10):1576-84. PubMed ID: 25231724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct medical costs of refractory epilepsy incurred by three different treatment modalities: a prospective assessment.
    Boon P; D'Havé M; Van Walleghem P; Michielsen G; Vonck K; Caemaert J; De Reuck J
    Epilepsia; 2002 Jan; 43(1):96-102. PubMed ID: 11879393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of vagus nerve stimulation on emergency department utilization in children with drug-resistant epilepsy: a retrospective cohort study.
    Muthiah N; Reecher HM; Abel TJ
    J Neurosurg Pediatr; 2024 Jun; ():1-8. PubMed ID: 38905712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of traditional and closed loop vagus nerve stimulation for treatment of pediatric drug-resistant epilepsy: A propensity-matched retrospective cohort study.
    Muthiah N; Akwayena E; Vodovotz L; Sharma N; Jeong JH; White GE; Abel TJ
    Seizure; 2022 Jan; 94():74-81. PubMed ID: 34872020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Vagal Nerve Stimulation for Drug-Resistant Epilepsy: Is it the Stimulation or Medication?
    Arcand J; Waterhouse K; Hernandez-Ronquillo L; Vitali A; Tellez-Zenteno JF
    Can J Neurol Sci; 2017 Sep; 44(5):532-537. PubMed ID: 28862106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrical stimulation for drug-resistant epilepsy: an evidence-based analysis.
    Chambers A; Bowen JM
    Ont Health Technol Assess Ser; 2013; 13(18):1-37. PubMed ID: 24228081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and economic impact of vagus nerve stimulation therapy in patients with drug-resistant epilepsy.
    Helmers SL; Duh MS; Guérin A; Sarda SP; Samuelson TM; Bunker MT; Olin BD; Jackson SD; Faught E
    Epilepsy Behav; 2011 Oct; 22(2):370-5. PubMed ID: 21872534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a clinical model to predict vagus nerve stimulation response in pediatric patients with drug-resistant epilepsy.
    Muthiah N; Mallela AN; Vodovotz L; Sharma N; Akwayena E; Pan E; Welch W; Ibrahim GM; Abel TJ
    J Neurosurg Pediatr; 2023 May; 31(5):476-483. PubMed ID: 36805960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating Long-Term Vagus Nerve Stimulation Effectiveness: Accounting for Antiepileptic Drug Treatment Changes.
    Révész D; Fröjd V; Rydenhag B; Ben-Menachem E
    Neuromodulation; 2018 Dec; 21(8):797-804. PubMed ID: 29608227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.